MARTIN, L.; ALIBHAI, S.; KOMISARENKO, M.; TIMILSHINA, N.; FINELLI, A. Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302. Canadian Urological Association Journal, v. 13, n. 6, 5 nov. 2018.